NASDAQ:BOLT | Free Cash Flow | Bolt Biotherapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.02M
2025-12-31-$7.16M$0.00-$7.16M
2025-03-31-$13.37M
2024-12-31-$14.43M$0.00-$14.43M
2024-03-31-$16.75M$0.00-$16.75M
2023-12-31-$14.27M$6,000.00-$14.27M
2023-03-31-$23.4M$3,000.00-$23.4M
2022-12-31-$17.95M$184,000.00-$18.14M
2022-03-31-$24.31M$605,000.00-$24.92M
2021-12-31-$17.79M$562,000.00-$18.36M
2021-03-31-$16.56M$58,000.00-$16.62M
2020-12-31-$12.89M$898,000.00-$13.79M
2020-03-31-$9.64M$373,000.00-$10.01M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$39.85M$72,000.00-$39.92M
2024-12-31-$61.29M$41,000.00-$61.33M
2023-12-31-$69.53M$206,000.00-$69.73M
2022-12-31-$76.5M$1.95M-$78.46M
2021-12-31-$57.07M$2.34M-$59.4M
2020-12-31-$47.31M$3.26M-$50.57M